Bal Pharma Ltd.
| BSE: 524824 | Sector: Health care |
| NSE: BALPHARMA | ISIN Code: INE083D01012 |
| BSE 00:00 | 29 Jun | 96.55 |
-2.00 (-2.03%) |
OPEN
96.75 |
HIGH
97.05 |
LOW
96.20 |
| NSE 00:00 | 29 Jun | 96.90 |
-1.80 (-1.82%) |
OPEN
97.80 |
HIGH
97.90 |
LOW
95.25 |
| OPEN | 96.75 |
| PREVIOUS CLOSE | 98.55 |
| VOLUME | 2592 |
| 52-Week high | 148.50 |
| 52-Week low | 87.50 |
| P/E | 17.52 |
| Mkt Cap.(Rs cr) | 150 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Bal Pharma Ltd. (BALPHARMA) - Announcements
-
Bal Pharma Ltd Closure of Trading Window
28/06/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Disclosure Of Related Party Transactions_31.03.2022
14/06/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Declaration Of Unmodified Opinion_ Audited Financial Results
08/06/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
01/06/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
31/05/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Audited Financial Results For F.Y 2021-22.
30/05/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Board Meeting Outcome for Out Come Of The Board Meeting
30/05/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance
26/05/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Certificate As Per Regulation 40(9) Of SEBI(LODR) Regulations2015.
19/04/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Allotment
13/04/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
13/04/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Compliance With Regulation 7(3) Of SEBI(LODR) Regulations.
06/04/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Board Meeting Intimation for Allotment Of Equity Shares Upon Conversion Of Warrants.
05/04/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
04/04/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Statement Of Investor Complaints For The Quarter Ended March 2022
04/04/2022 | bse
-
Bal Pharma Ltd Closure of Trading Window
31/03/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Board Meeting Outcome for Out Come Of The Board Meeting-Approval For Amalgamation Of Golden Drugs Pv
09/03/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Board Meeting Intimation for Approval Of Scheme Of Amalgamation.
28/02/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
25/02/2022 | bse |
Downlaod PDF -
Bal Pharma Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
24/02/2022 | bse |
Downlaod PDF
Quick Links for Bal Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
